1. Taximaimaiti, Reyisha, Li, Hongyan. 2019. MUL1 gene polymorphisms and Parkinson's disease risk. In Acta neurologica Scandinavica, 139, 483-487. doi:10.1111/ane.13081. https://pubmed.ncbi.nlm.nih.gov/30793286/
2. Liu, Lixiao, Zou, Chengyang, Shen, Jingtian, Guan, Yutao, Yan, Xiaojian. 2024. MUL1 identified as mitochondria-linked biomarker promoting cisplatin resistance in OC cells. In Gene, 930, 148841. doi:10.1016/j.gene.2024.148841. https://pubmed.ncbi.nlm.nih.gov/39134101/
3. Wu, Jilin, Huang, Ming, Dong, Wen, Lin, Tianxin, Chen, Xu. 2024. SUMO E3 ligase MUL1 inhibits lymph node metastasis of bladder cancer by mediating mitochondrial HSPA9 translocation. In International journal of biological sciences, 20, 3986-4006. doi:10.7150/ijbs.98772. https://pubmed.ncbi.nlm.nih.gov/39113711/
4. Chen, Chih-Wei, Su, Chi, Huang, Chang-Yu, Hunter, Tony, Chang, Zee-Fen. 2024. NME3 is a gatekeeper for DRP1-dependent mitophagy in hypoxia. In Nature communications, 15, 2264. doi:10.1038/s41467-024-46385-7. https://pubmed.ncbi.nlm.nih.gov/38480688/
5. Liu, Yujie, Liu, Hui, Yu, Guanliu, Yang, Guiwen, Chen, Lei. 2023. One-tube RPA-CRISPR Cas12a/Cas13a rapid detection of methicillin-resistant Staphylococcus aureus. In Analytica chimica acta, 1278, 341757. doi:10.1016/j.aca.2023.341757. https://pubmed.ncbi.nlm.nih.gov/37709482/